Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing

The CDC announced, albeit quietly, on Wednesday that the RT-PCR tests used to tell millions of Americans they’re infected with Covid-19 has been unable to accurately differentiate between the various coronaviruses. Of particular note is the inability of these tests to know whether someone is infected with Covid-19 or influenza.

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel.